Download PDF
doi: 10.53388/ghr2024001
Published online: March 29, 2024
Citation: Cui HT, Wang YM, Wang N. Shao Yao Decoction exerts a protective effect on ulcerative colitis by inhibiting inflammation mediated by hypercoagulability. Gastroenterol & Hepatol Res. 2024;6(1):1. doi: 10.53388/ghr2024001.
Shaoyao decoction (SYD) has been found widespread clinical use in treating ulcerative colitis (UC). However, the mechanism underlying SYD impact on UC remains elusive.
We preliminarily evaluated the therapeutic effect of SYD intervention in a dextran sulfate sodium-induced UC mouse model by analyzing the body weight change, disease activity index score, colon length, and HE staining results of colon tissue in each group of mice. Subsequently, we determined pro-inflammatory cytokines level and blood coagulation markers in the colon tissues of mice in each group to evaluate the effect of SYD intervention on colonic inflammatory response and coagulation function in UC mice.
Our findings emphasize the significant therapeutic effect of SYD on UC, including slowed down body weight loss, reduced disease activity index score, increased colon length, and reduced inflammatory infiltration in colon tissue. Moreover, SYD intervention significantly downregulated the levels of pro-inflammatory cytokines IL-1β, IL-6, and IL-17A in the colon. Furthermore, SYD intervention reversed the coagulation-related indicators such as prothrombin time, fibrinogen, P-selectin, D-dimer, and platelet glycomembrane protein IIb/IIIa.
Our results elucidate the substantial therapeutic impact of SYD on UC mice. Importantly, the therapeutic mechanism of SYD in addressing UC potentially involves the inhibiting of inflammatory response mediated by hypercoagulability.
Copyright © 2025 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.